← Back

Volitionrx Ltd

VolitionRx Limited is a multi-national epigenetics company that develops blood tests to help detect and monitor a range of cancers and diseases associated with NETosis. It operates in the United States, Europe, and Asia. Its products include Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, which detects diseases associated with NETosis such as sepsis; Nu.Q Discover, a nucleosome profiling solution; and Nu.Q Cancer, used to predict and monitor treatment response and disease progression and to adjust a patient's cancer treatment regimen. The company also offers Capture-PCR and Capture-Seq, which isolate and capture circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.

Price · split & dividend adjusted
News & notes moving VNRX